PDGFB-targeted functional MRI nanoswitch for activatable T-T dual-modal ultra-sensitive diagnosis of cancer.

J Nanobiotechnology

School of Medical Imaging, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, People's Republic of China.

Published: January 2023

As one of the most significant imaging modalities currently available, magnetic resonance imaging (MRI) has been extensively utilized for clinically accurate cancer diagnosis. However, low signal-to-noise ratio (SNR) and low specificity for tumors continue to pose significant challenges. Inspired by the distance-dependent magnetic resonance tuning (MRET) phenomenon, the tumor microenvironment (TME)-activated off-on T-T dual-mode MRI nanoswitch is presented in the current study to realize the sensitive early diagnosis of tumors. The tumor-specific nanoswitch is designed and manufactured on the basis of PDGFB-conjugating ferroferric oxide coated by Mn-doped silica (PDGFB-FMS), which can be degraded under the high-concentration GSH and low pH in TME to activate the T-T dual-mode MRI signals. The tumor-specific off-on dual-mode MRI nanoswitch can significantly improve the SNR and is used successfully for the accurate diagnosis of early-stage tumors, particularly for orthotopic prostate cancer. In addition, the systemic delivery of the nanoswitch did not cause blood or tissue damage, and it can be excreted out of the body in a timely manner, demonstrating excellent biosafety. Overall, the strategy is a significant step in the direction of designing off-on dual-mode MRI nanoprobes to improve imaging accuracy, which opens up new avenues for the development of new MRI probes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824934PMC
http://dx.doi.org/10.1186/s12951-023-01769-7DOI Listing

Publication Analysis

Top Keywords

dual-mode mri
16
mri nanoswitch
12
magnetic resonance
8
t-t dual-mode
8
off-on dual-mode
8
mri
7
nanoswitch
5
pdgfb-targeted functional
4
functional mri
4
nanoswitch activatable
4

Similar Publications

Efficient and Specific PDGFRβ-Targeting Dual-Mode T-T MRI Nanoprobe for Early Diagnosis of Non-Alcoholic Fatty Liver.

Adv Sci (Weinh)

March 2025

High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, P. R. China.

Non-alcoholic fatty liver disease (NAFLD)-induced early-stage liver fibrosis is increasingly common. Non-invasive MRI detection offers an important diagnostic method to prevent fibrosis from progressing to cirrhosis or hepatocellular carcinoma. However, because fibrosis is confined to the periportal areas, and changes in tissue structure and stiffness are minimal, standard T- or T-weighted imaging struggles to capture these early-stage lesions.

View Article and Find Full Text PDF

Iron oxide nanoparticles are a promising candidate for the dual-mode MRI contrast agent, however most of them have limited circulation time and predominant negative contrast. We developed citric acid stabilized superparamagnetic maghemite nanoparticles (CA-SPMNs) with size 3.2 ± 0.

View Article and Find Full Text PDF

Accurate and early tumor diagnosis is critical for effective cancer treatment, yet current diagnostic modalities often face limitations. Fluorescence imaging (FLI) and magnetic resonance imaging (MRI) both offer substantial potential for cancer diagnosis. However, FLI suffers from poor tissue penetration, while MRI lacks molecular specificity.

View Article and Find Full Text PDF

High-entropy oxides (HEOs) have attracted significant attention owing to their broad compositional tunability and high catalytic activity. However, research in this area is still in its early stages, and it is necessary to develop uniform multifunctional high-entropy nanozymes with appropriate sizes and excellent catalytic properties. In this study, we synthesized spherical high-entropy oxide composite carbon (HEO/C) nanoparticles (NPs) with a uniform distribution of particle size.

View Article and Find Full Text PDF

Transition-metal ion copper(II) (Cu(II)) has drawn increasing attention as a small-molecular cancer theranostic agent. However, delivering a sufficient dosage of Cu(II) to the tumor site and integrating multiple imaging modalities to achieve precise and effective cancer theranostics remains a critical challenge. Herein, an emerging Cu(II)-based nanocomposite has been synthesized for targeted tumor computed tomography (CT)/magnetic resonance (MR) dual-mode imaging and chemodynamic therapy (CDT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!